SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: moverman who wrote (46197)5/22/2018 11:25:05 AM
From: erickerickson7 Recommendations

Recommended By
captcobra1
corndog
erippetoe
idahoranch1
ladyPI

and 2 more members

   of 63276
 
Oh My. Management that acknowledges the hoi polloi exist. Whatever will we do now? Be still my heart.

Not only did the prior regime think investors were a necessary evil to be minimally acknowledged, but I never remember anything remotely like what that tweet is about. The prior regime didn't really have anything this buzz-worthy, but it's hard to imagine them doing anything like this even if they were still in control.

The TNBC foundation is clearly interested in 132, and IMMU is apparently perfectly willing to cooperate. Among other things this will help generate patient interest come approval. In this scenario the BLA gets approved and there's already a demand, or at least a number of people willing to ask their doctor "What's the story on this new drug from Immunomedics?".

And a brand new (but trained) sales force able to say "Let me tell you all about it"...

So my thinking here is that they are priming sales, publicity, patient demand, and doctors so they can hit the ground running after approval.

Hope the manufacturing is up to the demand ;)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News